Iomab-B
Actinium Pharmaceuticals
['sierra ']
$atnm actinium announces positive pivotal phase 3 sierra trial results in an oral presentation at the eha 2023 congress 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities